Inventor · disambiguated record
Adil Duran
Also filed as: DURAN ADIL
15 granted patents·4 pending applications·243 citations·filing 2005–2017
92Inventor score
Top patents by PatentIndex Score
19 records- 0197US7820815B2Process for the preparation of chiral 8-(-3-aminopiperidin-1-yl) xanthinesBOEHRINGER INGELHEIM INT·Filed 2005·Granted Oct 26, 2010·76 cites·13 claims
- 0296US7238807B2Process for the manufacture of fused piperazin-2-one derivativesBOEHRINGER INGELHEIM INT·Filed 2005·Granted Jul 3, 2007·65 cites·14 claims
- 0395US8883805B2Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthinesPFRENGLE WALDEMAR·Filed 2013·Granted Nov 11, 2014·28 cites·14 claims
- 0495US7626019B2Intermediate compounds for the manufacture of fused piperazin-2-one derivativesBOEHRINGER INGELHEIM INT·Filed 2007·Granted Dec 1, 2009·42 cites·1 claims
- 0591US8680280B2Process for the manufacturing of CRR inhibitorsDURAN ADIL·Filed 2013·Granted Mar 25, 2014·11 cites·14 claims
- 0688US8372974B2Regioselective preparation of substituted pyrimidinesBOEHRINGER INGELHEIM INT·Filed 2009·Granted Feb 12, 2013·6 cites·13 claims
- 0784US7524822B2Crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicamentsBOEHRINGER INGELHEIM INT·Filed 2007·Granted Apr 28, 2009·9 cites·10 claims
- 0879US8334383B2Regioselective preparation of substituted pyrimidinesDURAN ADIL·Filed 2009·Granted Dec 18, 2012·4 cites·11 claims
- 0969US8207335B2Process for making certain compounds having B1 antagonistic activityDURAN ADIL·Filed 2010·Granted Jun 26, 2012·1 cites·2 claims
- 1067US8420809B2Process for the manufacturing of betamimeticsKRUEGER THOMAS·Filed 2011·Granted Apr 16, 2013·1 cites·5 claims
- 1166US9499546B2Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthinesPFRENGLE WALDEMAR·Filed 2014·Granted Nov 22, 2016·0 cites·8 claims
- 1265US9751855B2Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthinesBOEHRINGER INGELHEIM INT·Filed 2017·Granted Sep 5, 2017·0 cites·3 claims
- 1361US7838500B2Crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicamentsAJINOMOTO KK·Filed 2009·Granted Nov 23, 2010·0 cites·26 claims
- 1460US2017029402A1Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthinesBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
- 1555US2013079518A1Regioselective preparation of substituted pyrimidinesLINZ GUENTER·Filed 2012·Application pending·0 cites
- 1653US8394791B2Crystalline, enantiomerically pure salt form of a beta-agonist, and the use thereof as a drugWERTHMANN ULRIKE·Filed 2009·Granted Mar 12, 2013·0 cites·7 claims
- 1750USRE43115EProcess for the manufacture of fused piperazin-2-one derivativesDURAN ADIL·Filed 2010·Granted Jan 17, 2012·0 cites·16 claims
- 1850US2007088160A1Process for the manufacturing of betamimeticsKRUEGER THOMAS·Filed 2006·Application pending·0 cites
- 1949US2013079519A1Regioselective preparation of substituted pyrimidinesDURAN ADIL·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →